Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2024 Dividend
February 06 2024 - 4:05PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
company’s Board of Directors has declared an increase of 2.7% in
the company’s quarterly cash dividend, beginning in the first
quarter of 2024. The increase will result in a quarterly dividend
of $0.77 per share of common stock. The dividend is payable on
March 28, 2024, to stockholders of record at the close of business
on March 15, 2024. Future dividends will be subject to Board
approval.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has
pursued and achieved breakthroughs in medicine for more than three
decades, with the goal of creating a healthier world for all
people. The company is committed to advancing innovative medicines
to prevent and treat life-threatening diseases, including HIV,
viral hepatitis, COVID-19, and cancer. Gilead operates in more than
35 countries worldwide, with headquarters in Foster City,
California.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240206319017/en/
Investors: Jacquie Ross, CFA
investor_relations@gilead.com
Media: Ashleigh Koss
public_affairs@gilead.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2024 to May 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From May 2023 to May 2024